on September 1, 2005
Published online before print September 1, 2005, doi: 10.1161/01.ATV.0000184758.07257.88
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 11, 2004
Accepted on June 29, 2005
Trichostatin A Exacerbates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient Mice
Jae-Hoon Choi ;
From the Departments of Veterinary Pathology (J-H.C., D.Y.K.) and Laboratory Animal Medicine (M.W.B.), College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National University, Seoul; the Laboratory of Cardiovascular Genomics (J-H.C., G.T.O.), Division of Molecular Life Science, Ewha Womans University, Seoul; the Laboratory of Animal Model Evaluation (K-H.N., J.K.), Korea Research Institute of Bioscience and Biotechnology, Dae-jeon; the Department of Internal Medicine (J.E.P.), College of Medicine, Sungkyunkwan University, Suwon; the Department of Biomedical Sciences (H.Y.P.), Division of Genetic Diseases, National Institute of Health, Seoul; the Department of Bioscience and Biotechnology (H.J.K.), Institute of Bioscience, Sejong University, Seoul; and Bioanalysis and Biotransformation Research Center (O.-S.K), Korea Institute of Science and Technology, Seoul, Korea.
* To whom correspondence should be addressed. E-mail: gootaeg{at}ewha.ac.kr.
Objective--Histone acetylation has been shown to be involved in expression of a restricted set of cellular genes including various proinflammatory molecules. We aimed to investigate the relationship between histone acetylation and atherosclerosis.
Methods and Results--In low-density lipoprotein (LDL) receptor-deficient (Ldlr-/-) mice fed an atherogenic diet for 4 or 8 weeks, trichostatin A (TSA), a specific histone deacetylase inhibitor, exacerbated atherosclerosis without alteration on plasma lipid profiles. When we assayed the effects of TSA on expressions of oxidized LDL (oxLDL) receptors on RAW264.7 macrophage, we found that TSA increased CD36 mRNA and protein, as well as cell surface expression of CD36. TSA also increased acetylation at the CD36 promoter region. The uptake of 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine percholate (Dil)-labeled oxLDL was enhanced in RAW264.7 macrophage by TSA. Furthermore, TSA treatment increased CD36 mRNA expression in aorta, and SRA, tumor necrosis factor (TNF)-
, and vascular cell adhesion molecule-1 (VCAM-1) were also elevated, whereas IL-6 and IL-1
expressions were decreased.
Conclusions--Our findings suggest that histone acetylation could play have some role in atherogenesis by modulating expressions of oxLDL receptor and some proatherogenic genes. Therefore, our results indicate that increased histone acetylation may affect the progress of atherosclerosis.
Key words: atherosclerosis • histone acetylatione • scavenger receptors • trichostatin A
This article has been cited by other articles:
 |
|
 |
|
  S. Song, S. W. Kang, and C. Choi Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1 Cardiovasc Res, August 13, 2009; (2009) cvp263v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. N'Guessan, F. Riediger, K. Vardarova, S. Scharf, J. Eitel, B. Opitz, H. Slevogt, W. Weichert, A. C. Hocke, B. Schmeck, et al. Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 380 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Bowes, M. I. Khan, Y. Shi, L. Robertson, and G. H. Werstuck Valproate Attenuates Accelerated Atherosclerosis in Hyperglycemic ApoE-Deficient Mice: Evidence in Support of a Role for Endoplasmic Reticulum Stress and Glycogen Synthase Kinase-3 in Lesion Development and Hepatic Steatosis Am. J. Pathol., January 1, 2009; 174(1): 330 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Matouk and P. A. Marsden Epigenetic Regulation of Vascular Endothelial Gene Expression Circ. Res., April 25, 2008; 102(8): 873 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, S. A. Mahmud, P. B. Bitterman, Y. Huo, and A. Slungaard Histone Deacetylase Inhibitors Suppress TF-{kappa}B-dependent Agonist-driven Tissue Factor Expression in Endothelial Cells and Monocytes J. Biol. Chem., September 28, 2007; 282(39): 28408 - 28418. [Abstract] [Full Text] [PDF]
|
|